Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Rockwell Medical, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Rockwell Medical received a Nasdaq non-compliance notice on May 8, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. This creates an immediate delisting risk that could severely impact the company's market access and investor confidence.
Key Takeaways
Company is in violation of Nasdaq Listing Rule 5550(a)(2) due to stock price falling below $1.00 minimum for 30+ consecutive business days
Failure to regain compliance could result in delisting from Nasdaq Capital Market, eliminating public trading access
2 more takeaways